Skip to content

ZLAB

Zai Lab Limited

NASDAQ · CNHealthcareBiotechnology
$20.52+1.58%

Price as of Jul 20, 2026

ZLAB capital

Zai Lab Limited capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity
0.35x
Net debt / equity
-0.63x
Debt / assets
0.21x
Debt / EBITDA
-1.46x
Net debt / EBITDA
2.65x

Liquidity & coverage

Current ratio
2.40x
Quick ratio
2.19x
Cash ratio
1.68x
Interest coverage
-42.83x
EBITDA / interest
-27.99x
Working capital
$551.7M

Cash & dividend

FCF / debt
-0.56x
Cash flow / debt
-0.44x
Dividend per share
Dividend yield
Dividend growth 1y

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.